Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

DAI Xiaoyu, ZHU Hai, ZHANG Xiaodong, ZHANG Xiaofang, ZONG Ying, DAI Yimin, ZHANG Shuying, YUAN Bojun, LU Guocai. Repeat-dose toxicity study of fibrin sealant in SD rats[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 231-234. doi: 10.3969/j.issn.1006-0111.2015.03.010
Citation: DAI Xiaoyu, ZHU Hai, ZHANG Xiaodong, ZHANG Xiaofang, ZONG Ying, DAI Yimin, ZHANG Shuying, YUAN Bojun, LU Guocai. Repeat-dose toxicity study of fibrin sealant in SD rats[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 231-234. doi: 10.3969/j.issn.1006-0111.2015.03.010

Repeat-dose toxicity study of fibrin sealant in SD rats

doi: 10.3969/j.issn.1006-0111.2015.03.010
  • Received Date: 2014-08-27
  • Rev Recd Date: 2014-12-30
  • Objective To evaluate the safety of fibrin sealant (FS) intraperitoneal injection in SD rats. Methods 80 male and female SD rats were randomly divided into four groups (0, 85.5, 171.0, 342.0 mg/kg) by body weight. All rats were intraperitoneally injected with vehicle or FS daily for 14 days followed by a 28-day recovery period. The clinical signs, hematological and biochemical indices were measured. The pathology were observed. Results Increase of white blood cell count (WBC) and decrease of fibrinogen (FIB) in d 14 were found in 171.0 mg/kg and 342.0 mg/kg dosage groups. Furthermore, the tendency of weight increase of spleen were found in 171.0 mg/kg and 342.0 mg/kg dosage groups. Pathological exams of peritoneal cavity found that there were granulation tissues containing FS in some of the rats in 342.0 mg/kg group. All of these changes got reversed after the recovery period. Conclusion The safety dose in this study is considered to be 85.5 mg/kg, and the toxicity dose is 171.0 mg/kg. The target toxicity systems or site of FS in SD rats are hematological system, immune system and injection site. The toxic effects of FS are reversible.
  • [1] Spotnitz WD.Hemostats,sealants,and adhesives:a practical guide for the surgeon[J].Am Surg,2012,78(12):1305-1321.
    [2] 王平瑜,白雪峰,王保卫,等.人纤维蛋白胶对人肝损伤的止血护创作用[J].中国医学创新,2011,8(6):9-11.
    [3] 谢钧韬,叶建宇,尹耀新,等.纤维蛋白封闭剂在腹腔镜胆囊切除术右副肝管处理中的应用[J].中华腔镜外科杂志(电子版),2010,3(2):205-207.
    [4] Mao Y, Xia ZN, Zhang XF,et al.Evaluation of subchronic toxicity of SIM010603,a potent inhibitor of receptor tyrosine kinase,after 28-day repeated oral administration in SD rats and beagle dogs[J].Food Chem Toxicol,2012,50(5):1256-1270.
    [5] Gong XL, Gao TT, Zhao LJ,et al.Subchronic safety evaluation of CMS-1 (a botanical antihypertensive product derived from Semen Cnidium monnieri)in Sprague-Dawley rats and beagle dogs[J].Regul Toxicol Pharmacol,2014,69(3):558-571.
    [6] 王春仁,王召旭,宋谊萍,等.医用纤维蛋白胶亚急性毒性实验研究[J].中国药事杂志,2007,21(7):472-477.
    [7] Bjorenson JE,Grove HF,List MG Sr,et al.Effects of hemostatic agents on the pH of body fluids[J].J Endod,1986,12:289.
    [8] Ibrahim MF,Aps C,Young CP.A foreign body reaction to Surgicel mimicking an abscess following cardiac surgery[J].Eur J Cardiothorac Surg,2002,22(3):489-490.
    [9] Chapman WC,Wren SM,Lebovic GS,et al.Effective management of bleeding tumor resection with a collagen-based hemostatic agent[J].Am Surg,2002,68(9):802-807.
    [10] Tomizawa Y.Clinical benefits and risk analysis of topical hemostats: a review [J].J Artif Organs,2005,8(3):137-142.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(3016) PDF downloads(829) Cited by()

Related
Proportional views

Repeat-dose toxicity study of fibrin sealant in SD rats

doi: 10.3969/j.issn.1006-0111.2015.03.010

Abstract: Objective To evaluate the safety of fibrin sealant (FS) intraperitoneal injection in SD rats. Methods 80 male and female SD rats were randomly divided into four groups (0, 85.5, 171.0, 342.0 mg/kg) by body weight. All rats were intraperitoneally injected with vehicle or FS daily for 14 days followed by a 28-day recovery period. The clinical signs, hematological and biochemical indices were measured. The pathology were observed. Results Increase of white blood cell count (WBC) and decrease of fibrinogen (FIB) in d 14 were found in 171.0 mg/kg and 342.0 mg/kg dosage groups. Furthermore, the tendency of weight increase of spleen were found in 171.0 mg/kg and 342.0 mg/kg dosage groups. Pathological exams of peritoneal cavity found that there were granulation tissues containing FS in some of the rats in 342.0 mg/kg group. All of these changes got reversed after the recovery period. Conclusion The safety dose in this study is considered to be 85.5 mg/kg, and the toxicity dose is 171.0 mg/kg. The target toxicity systems or site of FS in SD rats are hematological system, immune system and injection site. The toxic effects of FS are reversible.

DAI Xiaoyu, ZHU Hai, ZHANG Xiaodong, ZHANG Xiaofang, ZONG Ying, DAI Yimin, ZHANG Shuying, YUAN Bojun, LU Guocai. Repeat-dose toxicity study of fibrin sealant in SD rats[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 231-234. doi: 10.3969/j.issn.1006-0111.2015.03.010
Citation: DAI Xiaoyu, ZHU Hai, ZHANG Xiaodong, ZHANG Xiaofang, ZONG Ying, DAI Yimin, ZHANG Shuying, YUAN Bojun, LU Guocai. Repeat-dose toxicity study of fibrin sealant in SD rats[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(3): 231-234. doi: 10.3969/j.issn.1006-0111.2015.03.010
Reference (10)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return